$PL

Brennan Ita M sold $187K of PL

Brennan Ita M sold 11,500 shares of Planet Labs PBC (PL) at $16.30 ($0.19M total) on 2026-10-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Brennan Ita M
Published Oct 2, 2026, 10:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 2, 2026, 10:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PL
Neutral
medium confidence
Mentioned
$PL
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PLNeutralLow
01

Why it matters

The disclosed sale is modest and likely does not materially affect the stock price, but it provides transparency for shareholders.

02

Market read

A routine insider sale with limited market impact; primarily of interest to shareholders monitoring insider activity.

03

What to watch

If the director holds a larger undisclosed position or if multiple insiders are selling, cumulative pressure could be higher.

Relevance 3/10Novelty 3/10Timing: filing after market close on 2026‑10‑02

Background

SEC Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.

Company-level read

Ticker impact

$PLNeutralMedium confidence
Context

Director Brennan Ita M sold 11,500 shares (~$187K) of Planet Labs via a 10b5‑1 plan, reducing his stake to 250,373 shares.

Expected impact

potential slight downward pressure as the market digests the insider sell

Evidence & confidence

A $187K sale by a director is a routine 10b5‑1 transaction; size is modest, so any price effect is likely limited.

Market effects

Minimal impact on the satellite‑imagery sector; insider activity does not alter industry fundamentals.

No significant regional effect; the transaction is company‑specific.

Limited relevance; only investors tracking Planet Labs may note the sale.

Counterpoint

The sale could be a routine liquidity event unrelated to company outlook, so traders might ignore it.

Key entities

  • Planet Labs PBC

    US‑listed satellite‑imagery company (ticker PL).

  • Brennan Ita M

    Director of Planet Labs who executed the sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SPCXMed

SPCX Stock Outperforms Space Peers This Week As RKLB, ASTS, RDW And PL Slide

SpaceX (SPCX) gained 1% this week, while peers like Redwire (RDW), Rocket Lab (RKLB), AST SpaceMobile (ASTS), and Planet Labs (PL) declined. SpaceX acquired Grain Management's spectrum for $8B, pending FCC approval, and secured a deal with American Airlines for Starlink. Up to 328.4M SPCX shares may become eligible for sale on Friday. Other companies reported mixed operational updates and market sentiment.

$PLHigh

Effective Satellite Investment Amid High Multiples for Launch Peers – SatNews

Planet Labs PBC is highlighted as a lower-multiple investment in the commercial space sector, trading at 14.6x price-to-sales, compared to 96x for SpaceX and 55x for Rocket Lab. It reported Q2 revenue of $116.1M, up 58% YoY, with a 57% gross margin and positive free cash flow. Defense revenue surged over 90% YoY, but shares are down 18.15% YTD. Analysts rate it a 'Strong Buy' with a $34.78 target, implying 99% upside.